Cosmo Pharmaceuticals
C43.F
#5355
Rank
NZ$1.88 B
Marketcap
$117.35
Share price
-1.50%
Change (1 day)
60.06%
Change (1 year)

Earnings for Cosmo Pharmaceuticals (C43.F)

Earnings in 2022: NZ$44.62 Million

According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2022 the company made an earning of NZ$44.62 Million a decrease over its 2021 earnings that were of NZ$46.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cosmo Pharmaceuticals from 2004 to 2022

Annual earnings

Year Earnings Change
2022NZ$44.62 M-3.43%
2021NZ$46.21 M-418.87%
2020-NZ$14.5 Million-64.28%
2019-NZ$40.58 Million19.49%
2018-NZ$33.96 Million-48.67%
2017-NZ$66.16 Million-234.57%
2016NZ$49.15 M-89.6%
2015NZ$0.47 B110.02%
2014NZ$0.22 B33.75%
2013NZ$0.16 B177.69%
2012NZ$60.59 M201.84%
2011NZ$20.07 M99.1%
2010NZ$10.08 M-22.14%
2009NZ$12.95 M-53.08%
2008NZ$27.59 M7167.3%
2007NZ$0.37 M-66.41%
2006NZ$1.13 M-57.18%
2005NZ$2.64 M-193.84%
2004-NZ$2.82 Million